🔗 Share this article

Treasury head Rachel Reeves has stated she is preparing "focused action to tackle household expense issues" in the forthcoming financial statement.

Speaking to the BBC, she noted that lowering inflation is a shared duty of both the administration and the Bank of England.

The UK's inflation rate is forecast to be the most elevated among the Group of Seven developed nations this calendar year and the following year.

Possible Utility Bill Interventions

Reports indicate the administration could intervene to bring down utility costs, for instance by reducing the current 5% rate of value-added tax applied on energy supplies.

A further approach is to cut some of the policy costs presently added to household expenses.

Budgetary Constraints and Expert Predictions

The government will receive the next report from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will reveal how much scope there is for these actions.

The consensus from the majority of analysts is that Reeves will have to declare tax increases or expenditure reductions in order to meet her voluntary fiscal targets.

Previously on the same day, analysis showed there was a £22bn deficit for the Treasury chief to resolve, which is at the more modest range of forecasts.

"It is a joint task between the central bank and the administration to bear down further on some of the sources of inflation," Reeves informed the BBC in the US capital, at the annual meetings of the IMF and World Bank.

Revenue Pledges and Global Concerns

While much of the attention has been on probable tax increases, the Treasury chief said the most recent information from the OBR had not altered her pledge to manifesto promises not to raise tax levels on income tax, sales tax or National Insurance.

She attributed an "unpredictable global environment" with growing geopolitical and commercial concerns for the Budget revenue measures, probably to be targeted on those "wealthiest."

Global Trade Disputes

Commenting on apprehensions about the UK's trade ties with the Asian nation she said: "Our national security invariably are paramount."

Last week's declaration by China to increase export controls on rare earths and other resources that are key for high-technology manufacturing led US President Donald Trump to threaten an additional 100% import tax on goods from China, increasing the possibility of an all-out commercial conflict between the two global powers.

The American finance chief described China's move "commercial pressure" and "a global supply chain control attempt."

Asked about accepting the American proposal to participate in its conflict with the Asian nation, Reeves said she was "extremely troubled" by China's actions and urged the Beijing authorities "to avoid restrictions and restrict access."

She said the decision was "damaging for the international commerce and generates further headwinds."

"In my view there are fields where we need to challenge China, but there are also valuable opportunities to export to Chinese markets, including financial services and other areas of the economy. We've got to achieve that balance correct."

The Treasury chief also affirmed she was working with international partners "regarding our own essential resources approach, so that we are less reliant."

NHS Drug Pricing and Funding

Reeves also acknowledged that the price the National Health Service spends on pharmaceuticals could rise as a consequence of current talks with the US government and its drugs companies, in exchange for reduced taxes and capital.

Some of the world's largest drug companies have said in recent statements that they are either delaying or abandoning projects in the UK, with several blaming the modest returns they are getting.

Last month, the government science advisor said the price the NHS pays for drugs would need to increase to stop companies and drug research funding departing from the UK.

Reeves stated to media: "It has been observed as a result of the pricing regime, that medical research, new drugs have not been available in the United Kingdom in the manner that they are in other European countries."

"Our aim is to ensure that people getting care from the National Health Service are can obtain the finest critical treatments in the globe. And so we are looking at this situation, and... seeking to attract increased funding into the UK."